Probing the Bioactive Conformation of an Archetypal Natural Product HDAC Inhibitor Using Conformationally Homogeneous Triazole-Modified Cyclic Tetrapeptides

Ítems similars

• Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic α/β-Tetrapeptide Architectures
  per: Montero, Ana, et al.
  Publicat: (2009)
• Conformationally Homogeneous Heterocyclic Pseudo-Tetrapeptides as Three-Dimensional Scaffolds for Rational Drug Design: Mapping the Structural Basis Set and Application to the Design of Receptor-Selective Somatostatin Analogues
  per: Beierle, John M., et al.
  Publicat: (2009)
• Discovery of Potent and Selective Histone Deacetylase Inhibitors via Focused Combinatorial Libraries of Cyclic α(3)β-Tetrapeptides
  per: Olsen, Christian A., et al.
  Publicat: (2009)
• Histone Deacetylase Inhibitors: Synthesis of Cyclic Tetrapeptides and their Triazole Analogues
  per: Singh, Erinprit K., et al.
  Publicat: (2010)
• Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides That Restore Trafficking and Activity of ΔF508-CFTR
  per: Hutt, Darren M., et al.
  Publicat: (2011)